| Filed On | Filing |
|---|---|
| 23 Apr 2015 | CT ORDER |
| 02 Apr 2015 | RW |
| 01 Apr 2015 | RW |
| 17 Feb 2015 | SC 13G |
| 06 Oct 2014 | CT ORDER |
| 06 Oct 2014 | CT ORDER |
| 01 Oct 2014 | CT ORDER |
| 08 Jul 2014 | CT ORDER |
| 08 Jul 2014 | CT ORDER |
| 23 Jun 2014 | CT ORDER |
| 30 May 2014 | S-4 |
| 31 Mar 2014 | CT ORDER |
| 14 Feb 2014 | SCHEDULE 13G/A, #2 |
| 14 Feb 2014 | SC 13G/A |
| 14 Feb 2014 | SC 13G |
| 13 Jan 2014 |
Form 3: Bertrand William C Jr, Director
No securities owned |
| 13 Jan 2014 |
Form 3: Salix Pharmaceuticals Ltd, 10% owner and 2 others
Holds 100 shares of Common Stock |
| 13 Jan 2014 |
Form 3: Creech Timothy J, Director
No securities owned |
| 13 Jan 2014 | 15-12G |
| 06 Jan 2014 |
Form 4: Proehl Gerald T, Director
Received 233,341 shares as a grant or award ($1M) · Returned 233,341 shares to the issuer ($7.47M) · Disposed of 328,571 shares (Tender Offer) ($10.5M) · 3 more |
Loading...
